XML 47 R30.htm IDEA: XBRL DOCUMENT
v3.20.4

Quarterly Information (Unaudited) | 12 Months Ended
--- | ---
Dec. 31, 2020
Quarterly Financial Information Disclosure [Abstract] |
Quarterly Information (Unaudited) | 21. Quarterly Information (Unaudited) The tables below present summarized unaudited quarterly results of operations for the years ended December 31, 2020 and 2019. Management believes that all necessary adjustments have been included in the amounts stated below for a fair presentation of the results of operations for the periods presented when read in conjunction with the Company’s consolidated financial statements for the years ended December 31, 2020 and 2019. Results of operations for a particular quarter are not necessarily indicative of results of operations for an annual period and are not predictive of future periods.
|  | Quarter Ended |  |
|  | March 31, |  |  | June 30, |  |  | September 30, |  |  | December 31, |  |
|  | (In thousands except per share amounts) |  |
2020: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenue |  | $ | 509,217 |  |  | $ | 491,475 |  |  | $ | 547,961 |  |  | $ | 541,276 |  |
Income from continuing operations, net of taxes |  | $ | 21,251 |  |  | $ | 30,721 |  |  | $ | 45,063 |  |  | $ | 46,156 |  |
Income (loss) from discontinued operations, net of taxes |  | $ | 12,816 |  |  | $ | 10,993 |  |  | $ | (7,502 | ) |  | $ | (828,697 | ) | (1)
Net income (loss) attributable to Acadia Healthcare Company, Inc. stockholders |  | $ | 33,463 |  |  | $ | 41,079 |  |  | $ | 36,998 |  |  | $ | (783,672 | ) | (1)
Basic earnings per share attributable to Acadia Healthcare Company, Inc. stockholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Income from continuing operations attributable to Acadia Healthcare Company, Inc. |  | $ | 0.24 |  |  | $ | 0.34 |  |  | $ | 0.51 |  |  | $ | 0.51 |  |
Income (loss) from discontinued operations |  | $ | 0.14 |  |  | $ | 0.13 |  |  | $ | (0.09 | ) |  | $ | (9.42 | ) | (1)
Net (loss) income attributable to Acadia Healthcare Company, Inc. |  | $ | 0.38 |  |  | $ | 0.47 |  |  | $ | 0.42 |  |  | $ | (8.91 | ) | (1)
Diluted earnings per share attributable to Acadia Healthcare Company, Inc. stockholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Income from continuing operations attributable to Acadia Healthcare Company, Inc. |  | $ | 0.23 |  |  | $ | 0.34 |  |  | $ | 0.50 |  |  | $ | 0.50 |  |
Income (loss) from discontinued operations |  | $ | 0.15 |  |  | $ | 0.12 |  |  | $ | (0.08 | ) |  | $ | (9.28 | ) | (1)
Net (loss) income attributable to Acadia Healthcare Company, Inc. |  | $ | 0.38 |  |  | $ | 0.46 |  |  | $ | 0.42 |  |  | $ | (8.78 | ) | (1)
2019: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenue |  | $ | 487,960 |  |  | $ | 509,813 |  |  | $ | 509,383 |  |  | $ | 501,225 |  |
Income (loss) from continuing operations, net of taxes |  | $ | 13,618 |  |  | $ | 26,964 |  |  | $ | 24,920 |  |  | $ | (12,192 | ) | (2)
Income from discontinued operations, net of taxes |  | $ | 15,893 |  |  | $ | 21,237 |  |  | $ | 17,803 |  |  | $ | 1,879 |  | (2)
Net income (loss) attributable to Acadia Healthcare Company, Inc. stockholders |  | $ | 29,471 |  |  | $ | 48,140 |  |  | $ | 42,566 |  |  | $ | (11,254 | ) | (2)
Basic earnings per share attributable to Acadia Healthcare Company, Inc. stockholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Income (loss) from continuing operations attributable to Acadia Healthcare Company, Inc. |  | $ | 0.16 |  |  | $ | 0.31 |  |  | $ | 0.28 |  |  | $ | (0.15 | ) | (2)
Income from discontinued operations |  | $ | 0.18 |  |  | $ | 0.24 |  |  | $ | 0.21 |  |  | $ | 0.02 |  | (2)
Net income (loss) attributable to Acadia Healthcare Company, Inc. |  | $ | 0.34 |  |  | $ | 0.55 |  |  | $ | 0.49 |  |  | $ | (0.13 | ) | (2)
Diluted earnings per share attributable to Acadia Healthcare Company, Inc. stockholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Income (loss) from continuing operations attributable to Acadia Healthcare Company, Inc. |  | $ | 0.15 |  |  | $ | 0.31 |  |  | $ | 0.28 |  |  | $ | (0.15 | ) | (2)
Income from discontinued operations |  | $ | 0.19 |  |  | $ | 0.24 |  |  | $ | 0.20 |  |  | $ | 0.02 |  | (2)
Net income (loss) attributable to Acadia Healthcare Company, Inc. |  | $ | 0.34 |  |  | $ | 0.55 |  |  | $ | 0.48 |  |  | $ | (0.13 | ) | (2)
(1) | Includes U.K. loss on sale of $867.3 million which includes approximately $356.2 million of non-cash goodwill impairment.
(2) | Includes loss on impairment of $27.2 million in continuing operations and $27.2 million in discontinued operations.

X
- References No definition available. + Details
Name: | us-gaap_QuarterlyFinancialInformationDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -URI http://asc.fasb.org/topic&trid=2126967 + Details
Name: | us-gaap_QuarterlyFinancialInformationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration